Functional genomic studies: insights into the pathogenesis of liver cancer - PubMed (original) (raw)
Review
Functional genomic studies: insights into the pathogenesis of liver cancer
Ze-Guang Han. Annu Rev Genomics Hum Genet. 2012.
Abstract
Liver cancer is the sixth-most-common cancer overall but the third-most-frequent cause of cancer death. Among primary liver cancers, hepatocellular carcinoma (HCC), the major histological subtype, is associated with multiple risk factors, including hepatitis B and C virus infection, alcohol consumption, obesity, and diet contamination. Although previous studies have revealed that certain genetic and epigenetic changes, such as TP53 and β-catenin mutations, occur in HCC cells, the pathogenesis of this cancer remains obscure. Functional genomic approaches-including genome-wide association studies, whole-genome and whole-exome sequencing, array-based comparative genomic hybridization, global DNA methylome mapping, and gene or noncoding RNA expression profiling-have recently been applied to HCC patients with different clinical features to uncover the genetic risk factors and underlying molecular mechanisms involved in this cancer's initiation and progression. The genome-wide analysis of germline and somatic genetic and epigenetic events facilitates understanding of the pathogenesis and molecular classification of liver cancer as well as the identification of novel diagnostic biomarkers and therapeutic targets for cancer.
Similar articles
- Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S, Mao M. Li S, et al. Cancer Lett. 2013 Nov 1;340(2):247-53. doi: 10.1016/j.canlet.2012.09.027. Epub 2012 Oct 12. Cancer Lett. 2013. PMID: 23063663 Review. - Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM. Tornesello ML, et al. Genomics. 2013 Aug;102(2):74-83. doi: 10.1016/j.ygeno.2013.04.001. Epub 2013 Apr 11. Genomics. 2013. PMID: 23583669 Review. - Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.
Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM. Wurmbach E, et al. Hepatology. 2007 Apr;45(4):938-47. doi: 10.1002/hep.21622. Hepatology. 2007. PMID: 17393520 - Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.
Chen Y, Wang L, Xu H, Liu X, Zhao Y. Chen Y, et al. Oncol Rep. 2013 Oct;30(4):1906-12. doi: 10.3892/or.2013.2652. Epub 2013 Aug 2. Oncol Rep. 2013. PMID: 23912677 - Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H, Shibata T. Nakagawa H, et al. Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142287 Review.
Cited by
- Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory Circuit.
Li Y, Liu D, Zong Y, Qi J, Li B, Liu K, Xiao H. Li Y, et al. Mol Med. 2015 Apr 14;21(1):285-95. doi: 10.2119/molmed.2014.00173. Mol Med. 2015. PMID: 25879626 Free PMC article. - DNA methylation: potential biomarker in Hepatocellular Carcinoma.
Mah WC, Lee CG. Mah WC, et al. Biomark Res. 2014 Mar 17;2(1):5. doi: 10.1186/2050-7771-2-5. Biomark Res. 2014. PMID: 24635883 Free PMC article. - LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.
Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP, Gao YF. Chen ZZ, et al. Nat Commun. 2016 Aug 24;7:12598. doi: 10.1038/ncomms12598. Nat Commun. 2016. PMID: 27553854 Free PMC article. - Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway.
Zhuang J, He S, Wang G, Wang G, Ni J, Zhang S, Ye Y, Xia W. Zhuang J, et al. Oncol Res. 2018 Sep 14;26(8):1257-1265. doi: 10.3727/096504018X15172756878992. Epub 2018 Feb 20. Oncol Res. 2018. PMID: 29463348 Free PMC article. - Development of anticancer agents targeting the Wnt/β-catenin signaling.
Zhang X, Hao J. Zhang X, et al. Am J Cancer Res. 2015 Jul 15;5(8):2344-60. eCollection 2015. Am J Cancer Res. 2015. PMID: 26396911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous